» Articles » PMID: 38067153

Bile Acids in Autoimmune Liver Disease: Unveiling the Nexus of Inflammation, Inflammatory Cells, and Treatment Strategies

Overview
Journal Cells
Publisher MDPI
Date 2023 Dec 9
PMID 38067153
Authors
Affiliations
Soon will be listed here.
Abstract

As bile acids not solely play an essential role in nutrition absorption, but also in regulating metabolic functions as well as immune response, bile acids and their signaling pathways are increasingly acknowledged as potential therapeutic targets in the context of chronic liver diseases. Bile acid receptors such as G protein bile acid-activated receptor 1 and farnesoid X receptor are expressed in different immune cells engaged in innate immunity. Recently, a series of studies have revealed distinct functions of bile acids and bile acid receptors within the adaptive immune system. In addition, a variety of molecules targeting bile acid receptors and transporters are currently in advanced stages of clinical development. Autoimmune liver diseases including conditions like primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis can lead to chronic inflammation, fibrosis, and even cirrhosis and liver failure. In this review, we focus on the role of bile acids in the inflammatory aspects of autoimmune liver diseases.

Citing Articles

Alterations in bile acid kinetics after bariatric surgery in patients with obesity with or without type 2 diabetes.

Wahlstrom A, Aydin O, Olsson L, Sjoland W, Henricsson M, Lundqvist A EBioMedicine. 2024; 106:105265.

PMID: 39096744 PMC: 11345581. DOI: 10.1016/j.ebiom.2024.105265.


Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome.

Yang F, Zhou L, Shen Y, Wang X, Fan X, Yang L J Transl Med. 2024; 22(1):214.

PMID: 38424613 PMC: 10902991. DOI: 10.1186/s12967-024-05029-6.

References
1.
Sanyal A, Ling L, Beuers U, DePaoli A, Lieu H, Harrison S . Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases. JHEP Rep. 2021; 3(3):100255. PMC: 8056274. DOI: 10.1016/j.jhepr.2021.100255. View

2.
Hitomi Y, Nakamura M . The Genetics of Primary Biliary Cholangitis: A GWAS and Post-GWAS Update. Genes (Basel). 2023; 14(2). PMC: 9957238. DOI: 10.3390/genes14020405. View

3.
Xiao Y, Liu R, Li X, Gurley E, Hylemon P, Lu Y . Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia. Hepatology. 2019; 70(5):1658-1673. PMC: 6819224. DOI: 10.1002/hep.30698. View

4.
Wahlstrom A, Sayin S, Marschall H, Backhed F . Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. Cell Metab. 2016; 24(1):41-50. DOI: 10.1016/j.cmet.2016.05.005. View

5.
Czaja A . Cholestatic phenotypes of autoimmune hepatitis. Clin Gastroenterol Hepatol. 2013; 12(9):1430-8. DOI: 10.1016/j.cgh.2013.08.039. View